Condition
Emerging Infectious Disease
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Terminated1
Not Yet Recruiting1
Completed1
Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07559318Recruiting
Post-Emergency Optimization of Antibiotic Therapy for Urinary Tract Infection (UTI)
NCT06357650Not Yet Recruiting
Collaborative Open Research Initiative Study (CORIS-1)
NCT04891133Phase 2Terminated
EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform Trial
NCT04452695Completed
Acceptability of Telehealth Triage Using Robotic Systems in COVID-19
Showing all 4 trials